Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,656,499
+$535,547 QoQ
Shares Held
55,413
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#323
of 1,341 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beutel, Goodman & Co Ltd. holds $470,436,702 across 7 Drug Manufacturers - General names. NVO ranks #5 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,073,206 | $266,406,971 | |
| 2 | AMGN |
Amgen Inc
|
520,577 | $188,511,343 | |
| 3 | JNJ |
Johnson & Johnson
|
36,671 | $9,313,333 | |
| 4 | NVS |
Novartis AG
|
18,599 | $2,914,835 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
55,413 | $2,656,499 | |
| 6 | GSK |
GSK plc
|
11,584 | $607,233 | |
| 7 | PFE |
Pfizer Inc
|
1,100 | $26,488 |
All Filings in NVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,656,499 | 55,413 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,120,952 | 57,713 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,053,461 | 60,013 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,520,174 | 63,438 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,005,192 | 72,518 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,497,078 | 79,163 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||